Wealthfront Advisers LLC Amgen Inc Transaction History

Wealthfront Advisers LLC

$38.2 Billion
Q2 2025

A detailed history of Wealthfront Advisers LLC transactions in Amgen Inc stock. As of the latest transaction made, Wealthfront Advisers LLC holds 57,376 shares of AMGN stock, worth $16.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

57,376

Previous 66,065 13.15%

Holding current value

$16.7 Million

Previous $20.6 Million 22.17%

% of portfolio

0.04%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	SELL	$262.28 - $309.85 $2.28 Million - $2.69 Million	-8,689 Reduced 13.15%	57,376 $16 Million
Q1 2025 May 02, 2025	BUY	$258.59 - $327.36 $4.01 Million - $5.08 Million	15,521 Added 30.71%	66,065 $20.6 Million
Q4 2024 Apr 01, 2025	BUY	$258.78 - $328.31 $13.1 Million - $16.6 Million	50,544 New	50,544 $13.2 Million
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $121,586 - $132,590	-393 Reduced 0.73%	53,109 $17.1 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $757,508 - $920,570	2,883 Added 5.7%	53,502 $16.7 Million
Q1 2024 Apr 19, 2024	SELL	$268.87 - $324.56 $312,695 - $377,463	-1,163 Reduced 2.25%	50,619 $14.4 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $299,169 - $337,498	-1,170 Reduced 2.21%	51,782 $14.9 Million
Q3 2023 Nov 01, 2023	SELL	$218.65 - $271.46 $720,451 - $894,460	-3,295 Reduced 5.86%	52,952 $14.2 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $1.73 Million - $2.04 Million	-8,060 Reduced 12.53%	56,247 $12.5 Million
Q1 2023 Apr 28, 2023	SELL	$225.79 - $275.2 $351,555 - $428,486	-1,557 Reduced 2.36%	64,307 $15.5 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $2.06 Million - $2.62 Million	8,993 Added 15.81%	65,864 $17.3 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $2.42 Million - $2.73 Million	10,768 Added 23.36%	56,871 $12.8 Million
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $3.11 Million - $3.46 Million	13,473 Added 41.29%	46,103 $11.2 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.69 Million - $1.87 Million	7,691 Added 30.84%	32,630 $7.89 Million
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $811,231 - $928,380	-4,079 Reduced 14.06%	24,939 $5.61 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $1.02 Million - $1.2 Million	-4,814 Reduced 14.23%	29,018 $6.17 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $198,543 - $220,269	-850 Reduced 2.45%	33,832 $8.25 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $844,367 - $983,973	3,805 Added 12.32%	34,682 $8.63 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $518,230 - $617,119	-2,395 Reduced 7.2%	30,877 $7.1 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1,877 - $2,087	-8 Reduced 0.02%	33,272 $8.46 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $424,698 - $521,162	2,147 Added 6.9%	33,280 $7.85 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $1.54 Million - $2.05 Million	8,474 Added 37.4%	31,133 $6.31 Million
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $309,736 - $398,118	1,637 Added 7.79%	22,659 $5.46 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $367,023 - $439,770	2,108 Added 11.15%	21,022 $4.07 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $222,377 - $260,676	-1,334 Reduced 6.59%	18,914 $3.49 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $1.8 Million - $2.03 Million	-9,965 Reduced 32.98%	20,248 $3.85 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $5.39 Million - $6.29 Million	30,213 New	30,213 $5.88 Million

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

440M

Call Options Held

6.25M

Put Options Held

7.38M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthfront Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthfront Advisers LLC with notifications on news.

Account

Wealthfront Advisers LLC Amgen Inc Transaction History